Stryker Buys OEM Partner Gaymar Industries For $150 Million
This article was originally published in The Gray Sheet
Executive Summary
Stryker is acquiring support surface and pressure ulcer management company Gaymar Industries, with which it has had a long-time marketing arrangement, for $150 million, the firm announced Aug. 24
You may also be interested in...
Stryker may be candidate for Boston Sci neuromodulation biz
Stryker is reportedly in talks to acquire Boston Scientific's neuromodulation business for about $1.5 billion, although neither firm has publicly confirmed the discussions. Bloomberg reported Aug. 17 that the talks were in "advanced" stages. The Boston Sci neuromodulation biz, which makes spinal cord stimulation implants for pain management, would make "a good strategic fit" for Stryker's roughly $600 million spinal implant business and smaller pain management business, Wells Fargo Securities analyst Michael Matson said in an Aug. 18 report. Boston's neuromodulation sales increased 17% to $285 million in 2009. Reports first surfaced in April that Boston was considering selling its neuromodulation and neurovascular businesses. While neuromodulation has been Boston Scientific's fastest growing unit, the company may be willing to sell because of competitive pressures from Medtronic and St. Jude Medical and the investment that would be needed to catch up, some analysts say 1("The Gray Sheet" April 19, 2010)
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.